AU1574701A - A pharmaceutical composition containing pglu-glu-pro-nh2 and method for treating diseases and injuries to the brain, spinal cord and retina using same - Google Patents

A pharmaceutical composition containing pglu-glu-pro-nh2 and method for treating diseases and injuries to the brain, spinal cord and retina using same

Info

Publication number
AU1574701A
AU1574701A AU15747/01A AU1574701A AU1574701A AU 1574701 A AU1574701 A AU 1574701A AU 15747/01 A AU15747/01 A AU 15747/01A AU 1574701 A AU1574701 A AU 1574701A AU 1574701 A AU1574701 A AU 1574701A
Authority
AU
Australia
Prior art keywords
pglu
retina
injuries
glu
brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15747/01A
Inventor
Michael L. Koenig
Joseph B. Long
James L. Meyerhoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Walter Reed Army Institute of Research
Original Assignee
Walter Reed Army Institute of Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walter Reed Army Institute of Research filed Critical Walter Reed Army Institute of Research
Publication of AU1574701A publication Critical patent/AU1574701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
AU15747/01A 1999-10-22 2000-10-20 A pharmaceutical composition containing pglu-glu-pro-nh2 and method for treating diseases and injuries to the brain, spinal cord and retina using same Abandoned AU1574701A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16097299P 1999-10-22 1999-10-22
US60160972 1999-10-22
PCT/US2000/029278 WO2001028578A2 (en) 1999-10-22 2000-10-20 A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME

Publications (1)

Publication Number Publication Date
AU1574701A true AU1574701A (en) 2001-04-30

Family

ID=22579259

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15747/01A Abandoned AU1574701A (en) 1999-10-22 2000-10-20 A pharmaceutical composition containing pglu-glu-pro-nh2 and method for treating diseases and injuries to the brain, spinal cord and retina using same

Country Status (2)

Country Link
AU (1) AU1574701A (en)
WO (1) WO2001028578A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10105041A1 (en) 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases
DE10105038B4 (en) 2001-02-05 2005-07-07 Neurotell Ag Tripeptide derivatives for the treatment of postläsional diseases of the nervous system
DE10105040A1 (en) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide derivatives for the treatment of post-lesion diseases of the nervous system
US9289404B2 (en) * 2011-02-04 2016-03-22 Hough Ear Institute Methods for treating brain injury
WO2021059267A1 (en) * 2019-09-26 2021-04-01 S.I.S. Shulov Innovative Science Ltd. Compositions and methods for treating degenerative, age-related and trauma-induced disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions
DE3502041A1 (en) * 1985-01-23 1986-07-24 Grünenthal GmbH, 5190 Stolberg USE OF DIPEPTIDE DERIVATIVES FOR THE TREATMENT OF POSTTRAUMATIC NERVOUS DAMAGE
US5488145A (en) * 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps
US6432434B1 (en) * 1999-04-22 2002-08-13 The United States Of America As Represented By The Secretary Of The Army Treatment of and/or prophylaxis against brain and spinal cord injury

Also Published As

Publication number Publication date
WO2001028578A2 (en) 2001-04-26
WO2001028578A3 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
AU2002335736A1 (en) Composition and treatment method for brain and spinal cord injuries
HUP0103839A3 (en) Use of certain drugs for treating nerve root injury
HRP20020593A2 (en) Brain, spinal and nerve injury treatment
AU2746897A (en) Techniques for treating epilepsy by brain stimulation and drug infusion
AU4582797A (en) Methods for treatment of retinal diseases
IL148870A0 (en) 2'-substituted 1, 1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
ZA975866B (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
AU6530600A (en) Use of neurotoxin for treating cardiac muscle disorders
HK1040980A1 (en) Biphenylsulfonylcyanamides,process for their preparation, and their use as medicament
AU2364597A (en) Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
HU9501925D0 (en) Ortho-amine-substituted benzoyl-guanidine derivatives, process for producing them their pharmaceutical or diagnostical use, and pharmaceutical compositions containing them
AU1574701A (en) A pharmaceutical composition containing pglu-glu-pro-nh2 and method for treating diseases and injuries to the brain, spinal cord and retina using same
AU8893098A (en) Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as lung chronic and non specific conditions, sexually transmitted diseases and the resulting
HUP9600665A3 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
AUPQ232599A0 (en) Drug for treating fractures
AU2210701A (en) Process and apparatus for relaxing human organism and improvi ng general condition
HU9700989D0 (en) Ortho-substituted benzoyl-guanidines, process for producing them, their use as medicament and diagnosticment, pharmaceutical compositions containing them
AU5659798A (en) Therapeutic composition comprising the kal protein and use of the kal protein for the treatment of retinal, renal, neuronal and neural injury
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
AU3155497A (en) Substituted indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them
AU2509801A (en) Method for the cosmetic treatment of human skin
HRP980527B1 (en) Sulfonamid-substituted chromans, process for their preparation, their use as medicine, and pharmaceutical preparation containing them
AU2371397A (en) Substituted 1-naphthoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament containing them
AU2002223170A1 (en) Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions
HU9501546D0 (en) Sulphamide-derivatives, process for their preparation and their use as insecticides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase